Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianping Guo

Showing results (401-410 of 409) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 409 results.
Circulation. Cardiovascular Quality and Outcomes|January 5, 2024
Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network RegistrySarah Donnelly, Christopher F Barnett, Erin A Bohula, et al.
JAMA Network Open|November 10, 2022
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical TrialJing He, Jiali Chen, Miao Miao, et al.
Journal of Cardiac Failure|October 9, 2021
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network RegistryAnkeet S Bhatt, David D Berg, Erin A Bohula, et al.
Resuscitation|December 15, 2022
Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN)Anthony P Carnicelli, Ryan Keane, Kelly M Brown, et al.
Annals of the Rheumatic Diseases|December 14, 2017
Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese populationLeilei Wen, Caihong Zhu, Zhengwei Zhu, et al.
Journal of Medicinal Chemistry|November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.
Journal of Medicinal Chemistry|February 26, 2021
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven P Langston, Stephen Grossman, Dylan England, et al.
European Heart Journal. Acute Cardiovascular Care|August 28, 2023
Prognostic significance of haemodynamic parameters in patients with cardiogenic shockDavid D Berg, Gurleen Kaur, Erin A Bohula, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in EuropeansLei Jiang, Jian Yin, Lingying Ye, et al.
Pageof 41

Showing results (401-410 of 409) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 409 results.
Circulation. Cardiovascular Quality and Outcomes|January 5, 2024
Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network RegistrySarah Donnelly, Christopher F Barnett, Erin A Bohula, et al.
JAMA Network Open|November 10, 2022
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical TrialJing He, Jiali Chen, Miao Miao, et al.
Journal of Cardiac Failure|October 9, 2021
De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network RegistryAnkeet S Bhatt, David D Berg, Erin A Bohula, et al.
Resuscitation|December 15, 2022
Characteristics, therapies, and outcomes of In-Hospital vs Out-of-Hospital cardiac arrest in patients presenting to cardiac intensive care units: From the critical care Cardiology trials network (CCCTN)Anthony P Carnicelli, Ryan Keane, Kelly M Brown, et al.
Annals of the Rheumatic Diseases|December 14, 2017
Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese populationLeilei Wen, Caihong Zhu, Zhengwei Zhu, et al.
Journal of Medicinal Chemistry|November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.
Journal of Medicinal Chemistry|February 26, 2021
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven P Langston, Stephen Grossman, Dylan England, et al.
European Heart Journal. Acute Cardiovascular Care|August 28, 2023
Prognostic significance of haemodynamic parameters in patients with cardiogenic shockDavid D Berg, Gurleen Kaur, Erin A Bohula, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in EuropeansLei Jiang, Jian Yin, Lingying Ye, et al.
Pageof 41